FLQA Specialist jobs in United States
cer-icon
Apply on Employer Site
company-logo

CSL · 2 days ago

FLQA Specialist

CSL Seqirus is a leading provider of influenza vaccines, dedicated to protecting communities from seasonal influenza and global pandemic threats. The FLQA Specialist will apply quality principles related to equipment qualification and validation, ensuring compliance with cGMP and regulatory requirements while providing technical support and oversight in various operational areas.

BiotechnologyHealth CareHealth DiagnosticsMedical
check
Comp. & Benefits

Responsibilities

Ensure that qualification, validation, and technical protocols, and reports comply with site SOPs. Provide review and approval of related documents
Provide QA oversight to equipment qualification, technical transfers, process, method, cleaning and computer system validation including revalidation and re-evaluation
Maintain audit program, reviewing functional and release documentation, and reviewing and approving deviation investigations relevant to area(s) of responsibility
Review lot release documentation and Facilitate compliant release process for corresponding market
Respond to questions from authorities (Swissmedic, FDA, etc.) to ensure timely product release
Ensure standard operating procedures (SOP's) stay current and align with corporate and regulatory requirements
Interface with customers and partners on quality related issues
Execute training/awareness related to GMP standards
Provide training on quality concepts and tools

Qualification

GMP experienceCGMP principlesFDA requirementsEMA requirementsScientific degreeQuality oversightDeviation investigationTraining on quality

Required

University degree in a relevant scientific discipline (Pharmacy, Chemistry, Biology, Biochemistry)
3+ years' GMP experience in pharmaceutical/biotech or other regulated industry
Knowledge of current Good Manufacturing Practices (cGMP) principles
Knowledge of FDA and EMA requirements

Company

CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.

Funding

Current Stage
Public Company
Total Funding
$111M
2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO

Leadership Team

leader-logo
Jeffrey Ball
Chief Sustainability Officer
linkedin
leader-logo
Joy Linton
Strategic Advisor
linkedin
Company data provided by crunchbase